DrugCite
Search

CEFAZOLIN SODIUM

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Cefazolin Sodium Adverse Events Reported to the FDA Over Time

How are Cefazolin Sodium adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Cefazolin Sodium, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Cefazolin Sodium is flagged as the suspect drug causing the adverse event.

Most Common Cefazolin Sodium Adverse Events Reported to the FDA

What are the most common Cefazolin Sodium adverse events reported to the FDA?

Anaphylactic Reaction
108 (2.25%)
Anaphylactic Shock
88 (1.83%)
Pyrexia
79 (1.64%)
Rash
79 (1.64%)
Blood Pressure Decreased
77 (1.6%)
Erythema
70 (1.46%)
Hypotension
67 (1.39%)
Alanine Aminotransferase Increased
50 (1.04%)
Aspartate Aminotransferase Increase...
47 (.98%)
Pruritus
47 (.98%)
Urticaria
45 (.94%)
Show More Show More
Convulsion
44 (.92%)
Drug Rash With Eosinophilia And Sys...
43 (.9%)
Dyspnoea
42 (.87%)
Drug Hypersensitivity
41 (.85%)
Tachycardia
40 (.83%)
Depressed Level Of Consciousness
39 (.81%)
Toxic Epidermal Necrolysis
39 (.81%)
Medication Error
38 (.79%)
Drug Exposure During Pregnancy
36 (.75%)
Cardiac Arrest
35 (.73%)
Nausea
34 (.71%)
Hepatic Function Abnormal
31 (.65%)
Diarrhoea
30 (.62%)
Bronchospasm
29 (.6%)
Platelet Count Decreased
29 (.6%)
Loss Of Consciousness
28 (.58%)
Sepsis
26 (.54%)
Shock
26 (.54%)
Status Epilepticus
26 (.54%)
Generalised Erythema
25 (.52%)
Hypersensitivity
25 (.52%)
Renal Failure
23 (.48%)
Blood Creatinine Increased
22 (.46%)
Dysarthria
22 (.46%)
Pneumonia
22 (.46%)
Pancytopenia
21 (.44%)
Staphylococcal Infection
21 (.44%)
Disseminated Intravascular Coagulat...
20 (.42%)
Drug Eruption
20 (.42%)
Drug Ineffective
20 (.42%)
International Normalised Ratio Incr...
20 (.42%)
Rash Erythematous
20 (.42%)
Condition Aggravated
19 (.4%)
Headache
19 (.4%)
Malaise
19 (.4%)
Vomiting
19 (.4%)
Chills
18 (.37%)
Cough
18 (.37%)
Jaundice
18 (.37%)
Oedema
18 (.37%)
Poor Quality Drug Administered
18 (.37%)
Pseudomembranous Colitis
18 (.37%)
Thrombocytopenia
18 (.37%)
Chorioamnionitis
17 (.35%)
Hypertension
17 (.35%)
Stevens-johnson Syndrome
17 (.35%)
Caesarean Section
16 (.33%)
Hepatitis
16 (.33%)
Procedural Complication
16 (.33%)
Renal Failure Acute
16 (.33%)
Respiratory Failure
16 (.33%)
Abdominal Pain
15 (.31%)
Blood Pressure Systolic Decreased
15 (.31%)
Dyskinesia
15 (.31%)
Heart Rate Increased
15 (.31%)
Liver Disorder
15 (.31%)
Multi-organ Failure
15 (.31%)
Oxygen Saturation Decreased
15 (.31%)
Post Procedural Complication
15 (.31%)
Respiratory Arrest
15 (.31%)
Anaphylactoid Reaction
14 (.29%)
Blood Bilirubin Increased
14 (.29%)
Face Oedema
14 (.29%)
Haemolytic Anaemia
14 (.29%)
White Blood Cell Count Increased
14 (.29%)
Angioedema
13 (.27%)
Anxiety
13 (.27%)
Blister
13 (.27%)
Blood Creatine Phosphokinase Increa...
13 (.27%)
Cardio-respiratory Arrest
13 (.27%)
Cellulitis
13 (.27%)
Drug Interaction
13 (.27%)
Erythema Multiforme
13 (.27%)
Myoclonus
13 (.27%)
Wheezing
13 (.27%)
Blood Alkaline Phosphatase Increase...
12 (.25%)
Blood Lactate Dehydrogenase Increas...
12 (.25%)
Chest Pain
12 (.25%)
Dysphagia
12 (.25%)
Gamma-glutamyltransferase Increased
12 (.25%)
Haemorrhage
12 (.25%)
Respiratory Distress
12 (.25%)
Blood Urea Increased
11 (.23%)
Clostridium Difficile Colitis
11 (.23%)
Drug Level Increased
11 (.23%)
Electrocardiogram St Segment Elevat...
11 (.23%)
Heart Rate Decreased
11 (.23%)
Muscular Weakness
11 (.23%)
Ventricular Tachycardia
11 (.23%)
Arthralgia
10 (.21%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Cefazolin Sodium, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Cefazolin Sodium is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Cefazolin Sodium

What are the most common Cefazolin Sodium adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Cefazolin Sodium, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Cefazolin Sodium is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Cefazolin Sodium According to Those Reporting Adverse Events

Why are people taking Cefazolin Sodium, according to those reporting adverse events to the FDA?

Product Used For Unknown Indication
250
Drug Use For Unknown Indication
228
Infection Prophylaxis
194
Prophylaxis
163
Antibiotic Prophylaxis
142
Infection
69
Show More Show More
Preoperative Care
46
Pneumonia
32
Diarrhoea
31
Surgery
31
Pyrexia
26
Cellulitis
22
Prophylaxis Against Diarrhoea
21
Colitis Ulcerative
20
Ill-defined Disorder
20
Urinary Tract Infection
18
Staphylococcal Infection
17
Antibacterial Prophylaxis
16
Antibiotic Therapy
16
Premedication
15
Premature Rupture Of Membranes
14
Postoperative Care
12
Endocarditis
11
Constipation
10
Osteomyelitis
9
Proctitis
9
Bronchitis
8
Pyelonephritis
8
Anaesthesia
8
Wound Infection
8
Upper Respiratory Tract Infection
8
Abscess
7
Sepsis
7
Bacterial Infection
7
Infectious Peritonitis
7
Induction Of Anaesthesia
7
Gastroenteritis
6
Enterocolitis
6
Drug Exposure During Pregnancy
6
Sinusitis
6
Mycobacterium Ulcerans Infection
6
Pharyngitis Streptococcal
5
Inflammation
5
Haematochezia
5
Tumour Excision
5
Postoperative Infection
5
Systemic Antibacterial Therapy
4
Peritonitis Bacterial
4
Thermal Burn
4
Bowel Movement Irregularity
4
Cardiac Pacemaker Insertion
4

Drug Labels

LabelLabelerEffective
CefazolinGeneral Injectables & Vaccines, Inc12-APR-12
Cefazolin SodiumB. Braun Medical Inc.09-MAY-12
Cefazolin SodiumCantrell Drug Company24-OCT-12
Cefazolin SodiumCantrell Drug Company13-NOV-12

Cefazolin Sodium Case Reports

What Cefazolin Sodium safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Cefazolin Sodium. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Cefazolin Sodium.